Covestor’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$0 Buy
184
+103
+127% +$230 ﹤0.01% 2633
2026
Q2
$0 Hold
81
– – ﹤0.01% 2685
2026
Q1
$0 Hold
81
– – ﹤0.01% 2559
2025
Q4
$0 Hold
81
– – ﹤0.01% 2527
2025
Q3
$0 Hold
81
– – ﹤0.01% 2543
2025
Q2
$0 Hold
81
– – ﹤0.01% 2508
2025
Q1
$0 Hold
81
– – ﹤0.01% 2507
2024
Q4
$0 Buy
81
+15
+23% +$18 ﹤0.01% 2516
2024
Q3
$0 Hold
66
– – ﹤0.01% 2508
2024
Q2
$0 Hold
66
– – ﹤0.01% 2525
2024
Q1
$0 Hold
66
– – ﹤0.01% 2523
2023
Q4
$0 Sell
66
-8,319
-99% -$9.9K ﹤0.01% 2462
2023
Q3
$9K Hold
8,385
– – 0.01% 1487
2023
Q2
$19K Buy
+8,385
New +$22.3K 0.01% 1160

Other funds holding LXRX

Covestor's LXRX Position: Q3 2026 in Review

Covestor increased its Lexicon Pharmaceuticals (LXRX) stake by 127% in Q3 2026, buying an estimated $230 and bringing the position to 184 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2633.

Covestor first reported a position in LXRX in Q2 2023 and has held it in 14 quarters since. The position peaked at $19K in Q2 2023. 155 funds tracked by Wall St. Rank hold LXRX as of Q3 2026.

  • Covestor held 184 shares of Lexicon Pharmaceuticals worth $0 as of Q3 2026.
  • Covestor bought 103 Lexicon Pharmaceuticals shares in Q3 2026, an estimated $230.
  • Lexicon Pharmaceuticals made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2633 holding.
  • Covestor first reported a position in Lexicon Pharmaceuticals in Q2 2023 and has held it in 14 quarters since.
  • Covestor's Lexicon Pharmaceuticals position peaked at $19K in Q2 2023.
  • 155 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.